Press Releases

  GSK announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately.   He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty...

Teva Pharmaceutical Industries Ltd announced the launch of a generic equivalent of Epzicom®1 (abacavir and lamivudine) tablets, 600 mg/300 mg, in the United States (U.S.). Abacavir and lamivudine tablets are indicated in combination with other antiretroviral agents for the...

Gilead Sciences Inc announced it has entered into a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug donations over five years to expand access to diagnostic services and treatment for visceral leishmaniasis...

Vital Images, Inc. a Minneapolis-based advanced medical imaging and informatics company, will feature its enterprise interoperability solutions at the HIMSS Asia Pacific annual conference in booth 412, 23-26 August in Bangkok, Thailand. Vital's healthcare imaging informatics...

Arizona Instrument LLC is proud to announce the release of the Computrac® Vapor Pro® XL – the latest in a long line of accurate, reliable and easy to use moisture analyzers. About the Vapor Pro® XLThe...

Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral use, CII for the management of pain severe enough to require daily. ...

  AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment in patients with KRAS mutation-positive (KRASm) locally-advanced or metastatic non-small cell lung cancer (NSCLC). ...